BioCentury
ARTICLE | Finance

Intelligent diligence

How Roche thinks about due diligence in AI

March 8, 2018 6:05 PM UTC

Roche is foraying into artificial intelligence through a suite of partnering and M&A deals that are causing it to reinvent its due diligence process. The pharma is aiming to separate fact from fiction, and accurately assess technologies that lie beyond its core expertise in drug development.

In the last two months, Roche has signed three deals with data and analytics or AI companies aimed at rapidly expanding its precision medicine capabilities. ...